Rarity Bioscience
Uppsala, SE · Founded 2021 · 28 employees on LinkedIn · 3 known investors
Find your way into Rarity Bioscience
Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications. The company commercializes diagnostic assays and kits for clinical and research settings, with initial focus on leukemia and cancer detection.
Founders & leadership
Rarity Bioscience was founded in 2021 by Lei Chen, Ulf Landegren, and Per Matsson.
Investors · 3
Also in the syndicate · 1
UU Invest
Funding
SEC filings, press & company announcements- Undisclosed amountfunding roundJun 2024
Navigare Ventures (lead), Novalis Biotech, UU Invest
Source ↗ - Undisclosed amountseed roundNov 2022
Navigare Ventures, UU Invest
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Rarity Bioscience do?
- Rarity Bioscience develops superRCA, a molecular detection technology that identifies DNA mutations with exceptional sensitivity for precision medicine applications. The company commercializes diagnostic assays and kits for clinical and research settings, with initial focus on leukemia and cancer detection.
- Who founded Rarity Bioscience?
- Rarity Bioscience was founded by Lei Chen, Ulf Landegren, Per Matsson in 2021.
- Who are Rarity Bioscience's investors?
- Rarity Bioscience's investors include Navigare Ventures, Novalis Biotech.
- Where is Rarity Bioscience headquartered?
- Rarity Bioscience is headquartered in Uppsala, SE.